Winning the cGMP Whistleblower Game
Pharmaceutical Manufacturing Magazine
March, 2011
As one of the first qui tam attorneys to write on the application of False Claims Act to violations of the Current Good Manufacturing Practices (“cGMP“) Nolan Auerbach partner Kenneth Nolan is regularly contacted by the press to explain this use of the False Claims Act. Most recently, in an in-depth cover story, Pharmaceutical Manufacturing Magazine interviewed Nolan about how qui tam whistleblowers can use the False Claims Act to put the brakes on serious pharmaceutical manufacturing deficiencies.